BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ICB-USP | Instituto de Ciências Biomédicas - ECPv5.16.3.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:ICB-USP | Instituto de Ciências Biomédicas
X-ORIGINAL-URL:https://ww3.icb.usp.br
X-WR-CALDESC:Eventos para ICB-USP | Instituto de Ciências Biomédicas
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221219
DTEND;VALUE=DATE:20221220
DTSTAMP:20260520T082940
CREATED:20221109T125625Z
LAST-MODIFIED:20221212T104731Z
UID:14937-1671408000-1671494399@ww3.icb.usp.br
SUMMARY:New antimalarials: from drug discovery to clinical trials (19 e 20/12)
DESCRIPTION:  \nData: 19 e 20/12 \nHorário: 9h \nLocal: ICB II\, Sala “Samuel Pessoa”\, Av. Prof. Lineu Prestes\, nº 1374 – Butantã – São Paulo/SP – CEP 05508-000 \n  \nProgramação \n  \nSymposium – New antimalarials: from drug discovery to clinical trials This two-day international symposium is co-organized by the Department of Parasitology of the Institute of Biomedical Sciences\, University of São Paulo\, Brazil\, and the Centre for Malaria Research\, Department of Microbiology\,Tumor and Cell Biology\, Karolinska Institute\, Solna\, Sweden. Between 19 and 20 December\, 2022\, a series of conferences will cover several aspects of antimalarial drug development and testing\, including drug discovery strategies\, drug resistance surveillance\, pharmacogenomics\, and clinical trial design and execution. Students and post-doctoral fellows are invited to present their research projects and preliminary results as in-person short talks.All presentations will be in English. Confirmed speakers who will participate in-person or remotely via Zoom include: \n  \n\nAnna Caroline Aguiar (Federal University of São Paulo\, Brazil) (co-organizer)\nBrice Campo (Medicines for Malaria Venture)\nCélia R. S. Garcia (University of São Paulo\, Brazil)\nDaniel Y. Bargieri (University of São Paulo\, Brazil) (co-organizer)\nDavid A. Fidock (Columbia University\, United States)\nDhelio B. Pereira (Centro de Pesquisa em Medicina Tropical de Rondônia\, Brazil)\nGlaucius Oliva (University of São Paulo\, Brazil)\nGustavo Capatti Cassiano (Nova University of Lisbon\, Portugal)\nJosé Pedro Gil (Karolinska Institute\, Sweden; Nova University of Lisbon\, Portugal) (co-organizer)\nKim Williamson (Uniformed Services University of the Health Sciences\, United States)\nLeonardo J. Carvalho (Fiocruz\, Brazil)\nLeyre Pernaute (Karolinska Institute\, Swedenl)\nLise Musset (Pasteur Institute of Cayenne\, French Guiana)\nLuís Carlos Dias (University of Campinas\, Brazil)\nMarcelo U. Ferreira (University of São Paulo\, Brazil) (co-organizer)\nPedro Cravo (Nova University of Lisbon\, Portugal)\nTaís Nóbrega de Sousa (Karolinska Institute\, Sweden; Fiocruz\, Brazil)\n\n  \nStudent credits: Graduate students from the University of São Paulo or other Brazilian institutions who will attend the symposium in person can register into the graduate course “Scientific Bases of Malaria Eradication” (BMP5786) of the Graduate Program “Biology of the Host-Pathogen Relationships” and earn 2 credit units. \n  \nPlease contact Mrs. Silvia Camargo (pgbmp@icb.usp.br; with copy to muferrei@usp.br) regarding your registration. \nRegistration fee: There is no registration fee. \n  \nFinancial support: Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) and the Swedish Research Council.
URL:https://ww3.icb.usp.br/eventos/new-antimalarials/
END:VEVENT
END:VCALENDAR